国际标准期刊号: 2475-7640

临床与实验移植杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

An Overview on Transplantation Tolerance

Helen Cribb

Organ transplantation has become a common practice in modern medicine. With advancements in surgical techniques and immunosuppressive therapies, the success rates of organ transplantation have significantly increased, providing patients with a new lease of life. However, transplantation is not without its challenges. The immune system of recipients recognizes transplanted organs as foreign, triggering an immune response that can lead to graft rejection. This process is mediated by various immune cells and molecules, including T cells, B cells, antibodies, cytokines, and complement proteins. To prevent graft rejection, patients receive immunosuppressive drugs that suppress their immune system, but these drugs have side effects and can increase the risk of infections and cancer. Therefore, there is a need for alternative strategies to induce transplantation tolerance, which refers to the state of immune unresponsiveness towards the transplanted organ. Transplantation tolerance can eliminate or reduce the need for immunosuppressive drugs and improve the long-term outcomes of transplantation. In this article, we will review the current understanding of transplantation tolerance and the strategies that are being developed to achieve it.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。